1268.9000 -13.80 (-1.08%)
NSE Mar 20, 2026 15:31 PM
Volume: 16,745
 

1268.90
-1.08%
ICICI Securities Limited
Jupiter Life Line Hospital’s (Jupiter) Q3FY25 result undershot our expectation. Revenue growth of 17.6% was driven by its Pune/Indore hospitals while price hike fuelled modest growth at the Thane hospital. Dombivli (200–220 beds) hospital is likely to commence operations in Q1FY27.
Jupiter Life Line Hospitals Ltd. is trading above its 30 day SMA of 1260.6
More from Jupiter Life Line Hospitals Ltd.
Recommended